WallStreetZenWallStreetZen

NASDAQ: GNFT
Genfit Sa Stock

$3.65-0.02 (-0.54%)
Updated Mar 27, 2024
GNFT Price
$3.65
Fair Value Price
N/A
Market Cap
$181.90M
52 Week Low
$2.89
52 Week High
$4.75
P/E
-4.97x
P/B
2.29x
P/S
5.4x
PEG
N/A
Dividend Yield
N/A
Revenue
$31.65M
Earnings
-$37.55M
Gross Margin
100%
Operating Margin
-95.67%
Profit Margin
-114.9%
Debt to Equity
1.6
Operating Cash Flow
-$55M
Beta
0.59
Next Earnings
Apr 4, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GNFT Overview

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GNFT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GNFT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GNFT is good value based on its book value relative to its share price (2.29x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
GNFT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more GNFT due diligence checks available for Premium users.

Be the first to know about important GNFT news, forecast changes, insider trades & much more!

GNFT News

Valuation

GNFT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.97x
Industry
14.3x
Market
44.45x

GNFT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.29x
Industry
6.2x
GNFT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GNFT's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
GNFT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GNFT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$213.1M
Liabilities
$131.2M
Debt to equity
1.6
GNFT's short-term assets ($143.18M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GNFT's short-term assets ($143.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GNFT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GNFT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
GNFT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GNFT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GNFT$181.90M-0.54%-4.97x2.29x
LENZ$181.45M+30.29%-1.42x0.99x
ALDX$181.40M+5.48%-4.81x1.51x
SCPH$181.35M+2.44%-3.54x4.87x
SGMT$182.87M+9.56%-2.15x2.01x

Genfit Sa Stock FAQ

What is Genfit Sa's quote symbol?

(NASDAQ: GNFT) Genfit Sa trades on the NASDAQ under the ticker symbol GNFT. Genfit Sa stock quotes can also be displayed as NASDAQ: GNFT.

If you're new to stock investing, here's how to buy Genfit Sa stock.

What is the 52 week high and low for Genfit Sa (NASDAQ: GNFT)?

(NASDAQ: GNFT) Genfit Sa's 52-week high was $4.75, and its 52-week low was $2.89. It is currently -23.16% from its 52-week high and 26.17% from its 52-week low.

How much is Genfit Sa stock worth today?

(NASDAQ: GNFT) Genfit Sa currently has 49,834,983 outstanding shares. With Genfit Sa stock trading at $3.65 per share, the total value of Genfit Sa stock (market capitalization) is $181.90M.

Genfit Sa stock was originally listed at a price of $22.17 in Mar 27, 2019. If you had invested in Genfit Sa stock at $22.17, your return over the last 5 years would have been -83.54%, for an annualized return of -30.29% (not including any dividends or dividend reinvestments).

How much is Genfit Sa's stock price per share?

(NASDAQ: GNFT) Genfit Sa stock price per share is $3.65 today (as of Mar 27, 2024).

What is Genfit Sa's Market Cap?

(NASDAQ: GNFT) Genfit Sa's market cap is $181.90M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Genfit Sa's market cap is calculated by multiplying GNFT's current stock price of $3.65 by GNFT's total outstanding shares of 49,834,983.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.